[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK1289364T3 - Stabil gapapentin som indeholder mere end 20 ppm chlorioner - Google Patents

Stabil gapapentin som indeholder mere end 20 ppm chlorioner

Info

Publication number
DK1289364T3
DK1289364T3 DK01946364T DK01946364T DK1289364T3 DK 1289364 T3 DK1289364 T3 DK 1289364T3 DK 01946364 T DK01946364 T DK 01946364T DK 01946364 T DK01946364 T DK 01946364T DK 1289364 T3 DK1289364 T3 DK 1289364T3
Authority
DK
Denmark
Prior art keywords
stable
gapapentin
chlorine ions
ppm chlorine
ppm
Prior art date
Application number
DK01946364T
Other languages
English (en)
Inventor
Edi Schwartz
Claude Singer
Gideon Pilarski
Michael Pesachovich
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22788993&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1289364(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Application granted granted Critical
Publication of DK1289364T3 publication Critical patent/DK1289364T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Detergent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK01946364T 2000-06-16 2001-06-15 Stabil gapapentin som indeholder mere end 20 ppm chlorioner DK1289364T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21196700P 2000-06-16 2000-06-16
PCT/US2001/019100 WO2001097612A1 (en) 2000-06-16 2001-06-15 Stable gabapentin containing more than 2o ppm of chlorine ion

Publications (1)

Publication Number Publication Date
DK1289364T3 true DK1289364T3 (da) 2004-04-13

Family

ID=22788993

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01946364T DK1289364T3 (da) 2000-06-16 2001-06-15 Stabil gapapentin som indeholder mere end 20 ppm chlorioner

Country Status (12)

Country Link
US (1) US6531509B2 (da)
EP (1) EP1289364B1 (da)
AT (1) ATE255891T1 (da)
AU (1) AU2001268426A1 (da)
CA (1) CA2410867C (da)
DE (2) DE60101476T2 (da)
DK (1) DK1289364T3 (da)
ES (1) ES2193008T3 (da)
IL (1) IL153398A0 (da)
PT (1) PT1289364E (da)
TR (1) TR200302296T4 (da)
WO (1) WO2001097612A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ200339A3 (cs) * 2000-06-16 2003-06-18 Teva Pharmaceutical Industries Ltd. Stabilní gabapentin vykazující neutrální pH
US7056951B2 (en) * 2000-09-26 2006-06-06 Mutual Pharmaceutical Co., Inc. Stable solid dosage forms of amino acids and processes for producing same
US7612112B2 (en) 2001-10-25 2009-11-03 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
TWI312285B (en) 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
US20030119908A1 (en) * 2001-12-21 2003-06-26 Zambon Group S.P.A. Stable gabapentin compositions
DE60315258T2 (de) * 2002-12-20 2008-05-08 Dynogen Pharmaceuticals Inc., Waltham Behandlung von nicht-schmerzhaften blasenstörungen mit modulatoren der alpha-2-delta-untereinheit des calciumkanals
US20040198822A1 (en) * 2003-03-21 2004-10-07 Dynogen Pharmacueticals, Inc. Methods for treating lower urinary tract disorders using alpha2delta subunit calcium channel modulators with smooth muscle modulators
WO2005046566A2 (en) * 2003-08-04 2005-05-26 Sun Pharmaceutical Industries Limited Stable gabapentin containing composition
WO2005041928A1 (en) * 2003-10-31 2005-05-12 Alza Corporation Compositions and dosage forms for ehnanced absorption of iron
US20050187295A1 (en) * 2004-02-19 2005-08-25 Surendra Kalyan Processes for the preparation of gabapentin
US20070092565A1 (en) * 2005-10-25 2007-04-26 Pharmascience Inc. Gastric retention drug delivery system
NL2000281C2 (nl) 2005-11-02 2007-08-07 Pfizer Prod Inc Vaste farmaceutische samenstellingen die pregabaline bevatten.
US20090176882A1 (en) 2008-12-09 2009-07-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
CN101462975B (zh) * 2008-08-19 2012-07-25 宁波九胜创新医药科技有限公司 一种高纯度加巴喷丁的制备方法
CN116693410B (zh) * 2023-06-08 2024-06-07 浙江竹子制药有限公司 一种粒径可控的加巴喷丁制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087544A (en) 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
DE2460891C2 (de) 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2611690A1 (de) 1976-03-19 1977-09-22 Goedecke Ag Cyclische sulfonyloxyimide
US4894476A (en) 1988-05-02 1990-01-16 Warner-Lambert Company Gabapentin monohydrate and a process for producing the same
US4960931A (en) 1988-05-02 1990-10-02 Warner-Lambert Company Gabapentin mohohydrate and a process for producing the same
DE3928182A1 (de) 1989-08-25 1991-02-28 Goedecke Ag Verfahren zur herstellung von gabapentin
DE3928183A1 (de) 1989-08-25 1991-02-28 Goedecke Ag Lactamfreie cyclische aminosaeuren
DE3928184A1 (de) 1989-08-25 1991-02-28 Goedecke Ag Verfahren zur herstellung von cyclischen aminosaeurederivaten sowie zwischenprodukte
US5132451A (en) 1989-08-25 1992-07-21 Warner-Lambert Company Process for cyclic amino acid anticonvulsant compounds
AU633612B2 (en) 1989-08-25 1993-02-04 Warner-Lambert Company Improved process for cyclic amino acid anticonvulsant compounds
US5319135A (en) 1989-08-25 1994-06-07 Warner-Lambert Company Process for cyclic amino acid anticonvulsant compounds
US5084479A (en) 1990-01-02 1992-01-28 Warner-Lambert Company Novel methods for treating neurodegenerative diseases
US5025035A (en) 1990-10-12 1991-06-18 Warner-Lambert Company Method of treating depression
IL119890A (en) * 1996-12-24 2002-03-10 Teva Pharma Gabapentin form iii and preparation of gabapentin form ii
WO1999059573A1 (en) * 1998-05-15 1999-11-25 Warner-Lambert Company Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
PL205145B1 (pl) * 1998-05-15 2010-03-31 Warner Lambert Co Trwała kompozycja stała zawierająca pochodną 4-amino-3-podstawionego kwasu butanowego oraz sposób jej wytwarzania
FR2781793B1 (fr) 1998-08-03 2001-07-20 Prographarm Lab Procede de fabrication de granules de gabapentine enrobes
US6294198B1 (en) 1999-08-24 2001-09-25 Purepac Pharmaceutical Co. Pharmaceutical tablet formulation containing gabapentin with improved physical and chemical characteristics and method of making the same
US7056951B2 (en) * 2000-09-26 2006-06-06 Mutual Pharmaceutical Co., Inc. Stable solid dosage forms of amino acids and processes for producing same

Also Published As

Publication number Publication date
IL153398A0 (en) 2003-07-06
AU2001268426A1 (en) 2002-01-02
EP1289364B1 (en) 2003-12-10
DE60101476T2 (de) 2004-05-27
ES2193008T3 (es) 2004-07-01
EP1289364A1 (en) 2003-03-12
US6531509B2 (en) 2003-03-11
US20020061931A1 (en) 2002-05-23
CA2410867A1 (en) 2001-12-27
CA2410867C (en) 2003-12-09
DE60101476D1 (de) 2004-01-22
ATE255891T1 (de) 2003-12-15
TR200302296T4 (tr) 2004-02-23
EP1289364A4 (en) 2003-08-06
DE1289364T1 (de) 2003-09-18
ES2193008T1 (es) 2003-11-01
PT1289364E (pt) 2004-04-30
WO2001097612A1 (en) 2001-12-27

Similar Documents

Publication Publication Date Title
DK1289364T3 (da) Stabil gapapentin som indeholder mere end 20 ppm chlorioner
HUP9900152A2 (hu) Alkoholalapú mikrobaellenes kozmetikai készítmény és alkalmazása
BR0211390A (pt) Tratamento de infecções da unha com no
MXPA01012336A (es) Gel de silicon que contiene acido salicilico.
MXPA04006542A (es) Composiciones bucales estables que contienen complejos de fosfopeptido de caseina y fluooruro.
MXPA04004109A (es) Composiciones cosmeticas anhidras que contienen compuestos de amonio cuaternario.
HRP20020198B1 (en) Moxifloxacin formulation containing common salt
RS20050066A (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
MXPA03009651A (es) COMPOSICIoN ACUOSA DE DOS PARTES PARA LA COLORACIoN OXIDATIVA DEL CABELLO.
AU2003294785A1 (en) Hair treatment compositions
ATE288130T1 (de) Corona ionenquelle
MY133507A (en) New peroxy-carboxylic acid and aqueous compositions thereof
TW200501965A (en) Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle
NO20014101L (no) Stabilisert oral farmasöytisk blanding inneholdende iodid og iodat og fremgangsmåte
AR031782A1 (es) Dentifrico de astringencia reducida, que contiene zinc
ATE262277T1 (de) Wasser-dispergierbare agrochemische zusammensetzungen
FR2804319B1 (fr) Composition cosmetique amincissante comprenant en tant qu'agent actif un extrait de plante contenant de l'anp
TW200517117A (en) Stabilized compositions containing an oxygen-labile active agent
CO5580729A2 (es) Composiciones nutricionales que comprenden cistationina
WO2004039326A3 (en) Propofol with cysteine
TW200507838A (en) Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator
DK1307445T3 (da) Benzofuranderivater og deres anvendelse som antibakterielle midler
TR200401701T4 (tr) Zenginleştirilmiş besin ve terapötik etkinliğe sahip kreatin tuzu ve bunu içeren kompozisyonlar
ES2192136A1 (es) Composiciones farmaceuticas para el tratamiento o prevencion de la osteoporosis.
MY152837A (en) Disinfectant and/or bactericidal aqueous compositions